BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  AbbVie Pulls Plug on Parkinson’s Partnership With BioArctic

  AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s Disease and other movement disorders.

  April 20, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Career Advice

  8 Pharma Jobs for Those Who Love to Travel

  Keep reading to take a look at some of the best pharma jobs for travelers. These jobs will allow you to see different parts of the world while working in an exciting and fast-paced industry.

  April 20, 2022

   · 

  5 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  Teva, MedinCell Schizophrenia Drug Delayed over FDA Concerns

  The FDA has issued a Complete Response Letter (CRL) for TV-46000/mdc-IRM (risperidone extended-release injectable suspension for subcutaneous use) to Teva Pharmaceuticals and MedinCell.

  April 20, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Policy

  Gilead Secures Legal Victory in Battle Against HIV Drug Fraud

  Gilead Sciences scored a legal victory regarding fraudulent HIV reimbursements, securing a court order against a number of clinics, labs and prescribers in Florida that were engaging in the alleged fraud.

  April 20, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: BenevolentAI Takes on Dengue Fever in New Partnership

  Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

  April 20, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  GSK-Backed Researchers Bring New Meaning to Lupus Disease Modification

  Proposing a standardized definition of what disease modification looks like in SLE and LN that can drive outcomes measured in clinical trials, is an important step.

  April 20, 2022

   · 

  6 min read

   · 

  Hayley Shasteen
• 

  Business

  Coeptis Combines with Bull Horn in SPAC Deal to Advance CD38+ Assets

  Coeptis Therapeutics is merging with special purpose acquisition company Bull Horn Holdings in a definitive deal worth around $175 million.

  April 20, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Windtree is Bringing Patients Back from Cardiogenic Shock in Phase II

  New data unveiled by Windtree Therapeutics shows significant promise in heart failure patients who have deteriorated into cardiogenic shock.

  April 20, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Money on the Move: Tessera, Unlearn.AI, Blue Spark, Alzheon and Trevana

  The major money winners this week included a DNA editing platform, a machine-learning platform that creates digital patient “twins” and wearable temperature-monitoring patches.

  April 20, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Joseph Romanelli Returns to Merck as Head of Human Health International Division

  After a stint as head of a pharmaceutical company in China, Joseph Romanelli is returning to Merck as head of the human health international division.

  April 20, 2022

   · 

  2 min read

   · 

  Alex Keown